Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UK Biobank unveils world's largest genetic data set

In a momentous landmark for medical research, UK Biobank has today [Thursday 30 November] unveiled incredible new data from whole genome sequencing of its half a million participants.

4 Dec 2023

Study finds racial disparity in the utilization of crucial prostate cancer therapy

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

1 Dec 2023

UK Biobank data opens door to new era of precision medicine

In a momentous landmark for medical research, UK Biobank has today [Thursday 30 November] unveiled incredible new data from whole genome sequencing of its half a million participants.

29 Nov 2023

Racial residential segregation linked to widening health disparities

The U.S. must reduce racial residential segregation if it is to reduce racial disparities in health outcomes, according to a recently published study by researchers at Tufts University School of Medicine.

29 Nov 2023

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Obesity contributes to prostate cancer risk and can be inherited from obese fathers, as shown in a review of over 280 studies examining obesity's impact on carcinogenesis and heritability.

23 Nov 2023

Exploring the impact of soy isoflavones in prostate cancer therapy

The cellular mechanisms of soy isoflavones, genistein, daidzein, and equol.

23 Nov 2023

AI model predicts patient outcomes across multiple cancer types

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types.

16 Nov 2023

Research opens the door to a potential treatment strategy for certain advanced prostate cancers

Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks.

15 Nov 2023

New approach to CAR T cell therapy may extend treatment effectiveness

CAR T cell therapy, a powerful type of immunotherapy, has begun to revolutionize cancer treatment. Pioneered at Memorial Sloan Kettering Cancer Center (MSK), the therapy involves engineering a patient's T cells so they recognize and attack cancer cells.

14 Nov 2023

Facing financial ruin as costs soar for elder care

Margaret Newcomb, 69, a retired French teacher, is desperately trying to protect her retirement savings by caring for her 82-year-old husband, who has severe dementia, at home in Seattle.

14 Nov 2023

AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001

AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic Castration-Resistant Prostate Cancer (mCRPC).

13 Nov 2023

Multi-ancestry study reveals 187 new genetic risk factors for prostate cancer

In a comprehensive multi-ancestry GWAS meta-analysis, researchers identified 451 risk variants for prostate cancer, including 187 new variants, demonstrating the utility of such studies across diverse populations. This analysis not only increased understanding of genetic risk factors but also differentiated between aggressive and non-aggressive prostate cancer types, underscoring the potential of genetic risk scoring in guiding screening and early detection strategies.

12 Nov 2023

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet.

9 Nov 2023

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UK Biobank unveils world's largest genetic data set

Study finds racial disparity in the utilization of crucial prostate cancer therapy

UK Biobank data opens door to new era of precision medicine

Racial residential segregation linked to widening health disparities

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Exploring the impact of soy isoflavones in prostate cancer therapy

AI model predicts patient outcomes across multiple cancer types

Research opens the door to a potential treatment strategy for certain advanced prostate cancers

New approach to CAR T cell therapy may extend treatment effectiveness

Facing financial ruin as costs soar for elder care

AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001

Multi-ancestry study reveals 187 new genetic risk factors for prostate cancer

Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk

Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan

UTHSC's drug candidate for advanced prostate cancer goes to first clinical trial

High BMI in late teens linked to higher risk of 17 different cancers later in life

Black men may face an increased risk of prostate cancer than white men at lower PSA levels

Docetaxel improves survival in men with high-grade prostate cancer and low PSA

Highly sensitive blood test shows promise for early detection of common deadly cancers

Study offers the most comprehensive look to date on prostate cancer disparities

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in